These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 10659011

  • 1. Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration.
    Packer RJ, Raffel C, Villablanca JG, Tonn JC, Burdach SE, Burger K, LaFond D, McComb JG, Cogen PH, Vezina G, Kapcala LP.
    J Neurosurg; 2000 Feb; 92(2):249-54. PubMed ID: 10659011
    [Abstract] [Full Text] [Related]

  • 2. Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors.
    Kun LE, Gajjar A, Muhlbauer M, Heideman RL, Sanford R, Brenner M, Walter A, Langston J, Jenkins J, Facchini S.
    Hum Gene Ther; 1995 Sep; 6(9):1231-55. PubMed ID: 8527482
    [Abstract] [Full Text] [Related]

  • 3. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH.
    Cancer Res; 1993 Jan 01; 53(1):83-8. PubMed ID: 8380127
    [Abstract] [Full Text] [Related]

  • 4. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.
    Eck SL, Alavi JB, Alavi A, Davis A, Hackney D, Judy K, Mollman J, Phillips PC, Wheeldon EB, Wilson JM.
    Hum Gene Ther; 1996 Aug 01; 7(12):1465-82. PubMed ID: 8844206
    [Abstract] [Full Text] [Related]

  • 5. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group.
    Shand N, Weber F, Mariani L, Bernstein M, Gianella-Borradori A, Long Z, Sorensen AG, Barbier N.
    Hum Gene Ther; 1999 Sep 20; 10(14):2325-35. PubMed ID: 10515452
    [Abstract] [Full Text] [Related]

  • 6. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors.
    Ram Z, Culver KW, Walbridge S, Frank JA, Blaese RM, Oldfield EH.
    J Neurosurg; 1993 Sep 20; 79(3):400-7. PubMed ID: 8395592
    [Abstract] [Full Text] [Related]

  • 7. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir.
    Oldfield EH, Ram Z, Culver KW, Blaese RM, DeVroom HL, Anderson WF.
    Hum Gene Ther; 1993 Feb 20; 4(1):39-69. PubMed ID: 8384892
    [Abstract] [Full Text] [Related]

  • 8. Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.
    Xu F, Li S, Li XL, Guo Y, Zou BY, Xu R, Liao H, Zhao HY, Zhang Y, Guan ZZ, Zhang L.
    Cancer Gene Ther; 2009 Sep 20; 16(9):723-30. PubMed ID: 19363470
    [Abstract] [Full Text] [Related]

  • 9. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS.
    Cancer Res; 2001 Dec 15; 61(24):8743-50. PubMed ID: 11751394
    [Abstract] [Full Text] [Related]

  • 10. Treatment of progressive or recurrent glioblastoma multiforme in adults with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration: a phase I/II multi-institutional trial.
    Prados MD, McDermott M, Chang SM, Wilson CB, Fick J, Culver KW, Van Gilder J, Keles GE, Spence A, Berger M.
    J Neurooncol; 2003 Dec 15; 65(3):269-78. PubMed ID: 14682377
    [Abstract] [Full Text] [Related]

  • 11. Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir.
    Smitt PS, Driesse M, Wolbers J, Kros M, Avezaat C.
    Mol Ther; 2003 Jun 15; 7(6):851-8. PubMed ID: 12788659
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.
    Ram Z, Walbridge S, Heiss JD, Culver KW, Blaese RM, Oldfield EH.
    J Neurosurg; 1994 Mar 15; 80(3):535-40. PubMed ID: 8113867
    [Abstract] [Full Text] [Related]

  • 14. Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system.
    Raffel C, Culver K, Kohn D, Nelson M, Siegel S, Gillis F, Link CJ, Villablanca JG, Anderson WF.
    Hum Gene Ther; 1994 Jul 15; 5(7):863-90. PubMed ID: 7981311
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo.
    Lyons RM, Forry-Schaudies S, Otto E, Wey C, Patil-Koota V, Kaloss M, McGarrity GJ, Chiang YL.
    Cancer Gene Ther; 1995 Dec 15; 2(4):273-80. PubMed ID: 8548581
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
    Miura F, Moriuchi S, Maeda M, Sano A, Maruno M, Tsanaclis AM, Marino R, Glorioso JC, Yoshimine T.
    Gene Ther; 2002 Dec 15; 9(24):1653-8. PubMed ID: 12457278
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.